Effects of retinoic acid on NIH3T3 cell transformation by the H-ras oncogene
- PMID: 1706723
- PMCID: PMC12201298
- DOI: 10.1007/BF01613132
Effects of retinoic acid on NIH3T3 cell transformation by the H-ras oncogene
Abstract
Exposure of NIH3T3 cells to retinoic acid resulted in a dose-dependent modulation of transformed focus formation after transfection with an activated H-ras oncogene. Inhibition induced by 10 microM retinoic acid was maximal at 21.4% of control values. Maximal inhibition of transformation was found after exposure to 10 microM retinoic acid between days 0 and 3 of the transfection period. This concentration was also inhibitory for colony formation upon transfection of the non-transforming gene aph, suggesting that retinoic acid acts primarily on the process of transfection to inhibit focus or colony formation. Exposure to retinoic acid during the late period of the transfection protocol (days 14-20) resulted in alterations in focus morphology. A transformed cell line containing H-ras underwent reversion of the transformed phenotype after 4 weeks of treatment with retinoic acid, as determined by alterations in cell morphology and anchorage-independent growth. Phenotypic reversion was not associated with changes in the expression of the exogenous H-ras or endogenous c-myc or c-fos oncogenes.
Similar articles
-
A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.J Cancer Res Clin Oncol. 1997;123(2):91-9. doi: 10.1007/BF01269886. J Cancer Res Clin Oncol. 1997. PMID: 9030247 Free PMC article.
-
Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.J Cancer Res Clin Oncol. 1990;116(1):29-37. doi: 10.1007/BF01612637. J Cancer Res Clin Oncol. 1990. PMID: 1690210 Free PMC article.
-
7-Hydroxycoumarin inhibits oncogene-induced transformation of murine fibroblasts.J Cancer Res Clin Oncol. 1994;120 Suppl(Suppl 1):S23-7. doi: 10.1007/BF01377119. J Cancer Res Clin Oncol. 1994. PMID: 8132698 Free PMC article.
-
Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010685. doi: 10.1002/14651858.CD010685.pub3. Cochrane Database Syst Rev. 2017. PMID: 28840597 Free PMC article.
-
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.Cochrane Database Syst Rev. 2015 Jan 29;1:CD010685. doi: 10.1002/14651858.CD010685.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Aug 25;8:CD010685. doi: 10.1002/14651858.CD010685.pub3. PMID: 25634649 Updated.
Cited by
-
Retinoid-dependent pathways suppress myocardial cell hypertrophy.Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7391-5. doi: 10.1073/pnas.92.16.7391. Proc Natl Acad Sci U S A. 1995. PMID: 7638203 Free PMC article.
References
-
- Fitzgerald DJ, Barrett JC, Nettesheim P (1986) Changing responsiveness to all-trans retinoic acid of rat tracheal epithelial cells at different stages of neoplastic transformation. Carcinogenesis 7:1715–1721 - PubMed
-
- Garte SJ, Currie D, Troll W (1987) Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors. Cancer Res 47:3159–3162 - PubMed
-
- Garte SJ, Currie D, Motz J, Troll W (1988) Retinoic acid inhibits transformation of NIH3T3 cells by the human H-ras oncogene. Proc Am Assoc Cancer Res 29:140
-
- Giese NA, Neary KE, Levine N, Duffy JJ (1985) Inhibition by retinoic acid of murine retrovirus-induced cellular transformation and tumor formation. J Natl Cancer Inst 74:1135–1144 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous